GLP-1 medications may quiet the brain signals behind addiction, reducing substance use disorders and overdose risk across ...

Research suggests the drugs have potential for prevention and harm reduction in substance use disorders, writes Ziyad Al-Aly People taking glucagon-like peptide-1 (GLP-1) receptor agonists often ...

People struggling with many addictions, ranging from opioids to gambling, are reporting similar experiences in clinics, on ...

A study of more than 600,000 veterans found that GLP-1 drugs — originally designed for diabetes and weight loss — cut ...

Large veteran study links GLP-1 diabetes drugs to lower risk of developing substance use disorders and fewer overdoses, hospitalizations and drug-related deaths.

A large new study suggests they may drastically reduce the risk substance use disorders and drug-related deaths.

Weight-loss drug users were less likely to suffer many common addictions including to alcohol, cannabis, cocaine, nicotine, ...

Researchers at Washington University School of Medicine in St. Louis have shown in a new study that GLP-1 medications may be ...

Between four and 10 million people in the U.S. have fibromyalgia. Many doctors look askance at the disorder, leading some ...